Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E K Vanhoutte

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Neurology|January 26, 2011
Rasch-built Overall Disability Scale (R-ODS) for immune-mediated peripheral neuropathiesS I van Nes, E K Vanhoutte, P A van Doorn, et al.
European Journal of Neurology|August 16, 2012
Vigorimeter grip strength in CIDP: a responsive tool that rapidly measures the effect of IVIG--the ICE studyE K Vanhoutte, N Latov, C Deng, et al.
European Journal of Neurology|April 30, 2016
Correlation of the patient's reported outcome Inflammatory-RODS with an objective metric in immune-mediated neuropathiesT H P Draak, K C Gorson, E K Vanhoutte, et al.
European Journal of Cancer (Oxford, England : 1990)|May 15, 2013
Rasch-built Overall Disability Scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS)D Binda, E K Vanhoutte, G Cavaletti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 23, 2012
The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findingsG Cavaletti, D R Cornblath, I S J Merkies, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Neurology|January 26, 2011
Rasch-built Overall Disability Scale (R-ODS) for immune-mediated peripheral neuropathiesS I van Nes, E K Vanhoutte, P A van Doorn, et al.
European Journal of Neurology|August 16, 2012
Vigorimeter grip strength in CIDP: a responsive tool that rapidly measures the effect of IVIG--the ICE studyE K Vanhoutte, N Latov, C Deng, et al.
European Journal of Neurology|April 30, 2016
Correlation of the patient's reported outcome Inflammatory-RODS with an objective metric in immune-mediated neuropathiesT H P Draak, K C Gorson, E K Vanhoutte, et al.
European Journal of Cancer (Oxford, England : 1990)|May 15, 2013
Rasch-built Overall Disability Scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS)D Binda, E K Vanhoutte, G Cavaletti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 23, 2012
The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findingsG Cavaletti, D R Cornblath, I S J Merkies, et al.
Pageof 1